Franklin Street Advisors Inc Gilead Sciences, Inc. Transaction History

Franklin Street Advisors Inc

$1.48 Billion
Q3 2024

A detailed history of Franklin Street Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Franklin Street Advisors Inc holds 6,950 shares of GILD stock, worth $642,249. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,950

Previous 6,950 -0.0%

Holding current value

$642,249

Previous $477,000 22.22%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$63.15 - $72.88 $39,342 - $45,404	-623 Reduced 8.23%	6,950 $477,000
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $21,474 - $26,187	-300 Reduced 3.81%	7,573 $555,000
Q2 2023 Jul 13, 2023	BUY	$76.01 - $86.7 $22,803 - $26,010	300 Added 3.96%	7,873 $607,000
Q3 2022 Oct 11, 2022	SELL	$59.54 - $68.01 $15,778 - $18,022	-265 Reduced 3.38%	7,573 $467,000
Q2 2022 Jul 13, 2022	SELL	$57.72 - $65.01 $7,503 - $8,451	-130 Reduced 1.63%	7,838 $484,000
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $8,398 - $10,524	-145 Reduced 1.79%	7,968 $474,000
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $35,619 - $40,428	-549 Reduced 6.34%	8,113 $589,000
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $169,360 - $182,721	-2,502 Reduced 22.41%	8,662 $605,000
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $6,347 - $6,934	-100 Reduced 0.89%	11,164 $769,000
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $6,000 - $6,845	100 Added 0.9%	11,264 $728,000
Q4 2020 Feb 01, 2021	SELL	$56.65 - $64.55 $99,137 - $112,962	-1,750 Reduced 13.55%	11,164 $650,000
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $52,785 - $66,368	850 Added 7.05%	12,914 $816,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $6,872 - $7,980	-95 Reduced 0.78%	12,064 $928,000
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $26,930 - $34,494	430 Added 3.67%	12,159 $909,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $36,725 - $40,396	-596 Reduced 4.84%	11,729 $762,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $6,251 - $6,900	-100 Reduced 0.8%	12,325 $781,000
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $92,495 - $103,723	1,495 Added 13.68%	12,425 $839,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $7,190 - $8,055	-115 Reduced 1.04%	10,930 $711,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $6.42 Million - $8.37 Million	-105,963 Reduced 90.56%	11,045 $691,000
Q3 2018 Oct 05, 2018	BUY	$71.28 - $78.92 $222,821 - $246,703	3,126 Added 2.74%	117,008 $9.03 Million
Q2 2018 Jul 16, 2018	BUY	$64.88 - $75.68 $20,761 - $24,217	320 Added 0.28%	113,882 $8.07 Million
Q1 2018 Apr 11, 2018	BUY	$72.84 - $88.8 $110,352 - $134,532	1,515 Added 1.35%	113,562 $8.56 Million
Q4 2017 Jan 10, 2018	BUY	$71.15 - $83.52 $441,983 - $518,826	6,212 Added 5.87%	112,047 $8.03 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $7.63 Million - $9.05 Million	105,835	105,835 $8.58 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Account

Franklin Street Advisors Inc Gilead Sciences, Inc. Transaction History